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Neural stem cells (NSCs) continuously produce new
neurons within the adult mammalian hippocampus.
NSCs are typically quiescent but activated to self-
renew or differentiate into neural progenitor cells.
The molecular mechanisms of NSC activation remain
poorly understood. Here, we show that adult hippo-
campal NSCs express vascular endothelial growth
factor receptor (VEGFR) 3 and its ligand VEGF-C,
which activates quiescent NSCs to enter the cell
cycle and generate progenitor cells. Hippocampal
NSC activation and neurogenesis are impaired by
conditional deletion of Vegfr3 in NSCs. Functionally,
this is associated with compromised NSC activa-
tion in response to VEGF-C and physical activity.
In NSCs derived from human embryonic stem cells
(hESCs), VEGF-C/VEGFR3 mediates intracellular
activation of AKT and ERK pathways that control
cell fate and proliferation. These findings identify
VEGF-C/VEGFR3 signaling as a specific regulator
of NSC activation and neurogenesis in mammals.
INTRODUCTION
The adult mammalian brain continuously produces new neu-
rons in two discrete regions, the subventricular zone (SVZ) lin-
ing the ventricles and the dentate gyrus (DG) of the hippocam-
pus (Altman and Das, 1965; Doetsch et al., 1999). In rodents,
hippocampal neurogenesis is enhanced by external factors,
including an enriched environment and voluntary running exer-1158 Cell Reports 10, 1158–1172, February 24, 2015 ª2015 The Authcise (Brown et al., 2003; Vivar and van Praag, 2013). A decline
in hippocampal neurogenesis occurs with age and may under-
lie cognitive and mood alterations associated with aging
and Alzheimer’s disease (Lazarov et al., 2010; Mu and Gage,
2011).
Hippocampal neurogenesis occurs within the subgranular
zone (SGZ) of the DG and is initiated by neural stem cells
(NSCs), which undergo a series of divisions to generate new
granular layer interneurons that integrate into the hippocampal
circuitry (Kempermann et al., 2004). NSCs include a quiescent
population, which are radial glia-like cells (RGLs) (or type-1
cells) that are characterized by the expression of Nestin,
GFAP, Sox2, and Hes5 (Bonaguidi et al., 2011; Encinas
et al., 2011; Lugert et al., 2010; Suh et al., 2007). NSC activa-
tion is upon Ascl1 regulation (Andersen et al., 2014) and leads
to generate proliferative progenitors, known as intermediate
progenitors (IPCs), which in turn give rise to committed neu-
ronal progenitors (neuroblasts). Whereas the steps of hippo-
campal neuron formation have been well characterized (Bona-
guidi et al., 2012; Kempermann et al., 2004), the molecular
mechanisms controlling this cellular progression remain poorly
understood.
Several signaling pathways are known to maintain hippo-
campal NSC quiescence through inhibition of cell proliferation.
Conditional disruption of the genes encoding BMP2 and 4,
sFRP3, Notch/RBP-J, and REST in RGLs all result in rapid
activation of NSC division, leading to a transient increase in
IPC numbers and production of new adult hippocampal neu-
rons (Ehm et al., 2010; Gao et al., 2011; Jang et al., 2013;
Mira et al., 2010). In contrast to these repressors of NSC
activation, only a few positive regulators of NSC division and
progenitor cell production are known. These include sonic
hedgehog/smoothened and BDNF/TrkB, but both of theseors
signaling pathways are also active in other subpopulations of
the hippocampal niche (Li et al., 2008; Machold et al., 2003).
Identification of NSC-selective positive regulators should allow
prolonging or enhancing neurogenesis during aging and
improve the efficacy of NSC-based repair therapies, especially
in older patients.
Vascular endothelial growth factors (VEGFs) and their high-
affinity tyrosine kinase receptors (VEGFRs) are potent regula-
tors of the growth and maintenance of vascular and neural
cells (Eichmann and Thomas, 2013; Zacchigna et al., 2008).
In the hippocampus, VEGF-A increases angiogenesis, neuro-
genesis, and neuronal plasticity (During and Cao, 2006; Four-
nier and Duman, 2012; Licht and Keshet, 2013). However, it
is not clear whether VEGF-A enhances neurogenesis directly,
through its receptors VEGFR1 and 2 on neural cells, or indi-
rectly, through factors released from newly formed blood ves-
sels. The related growth factor VEGF-C is a potent regulator of
lymphangiogenesis (Lohela et al., 2009). VEGF-C also induces
angiogenesis but only weakly, as expression of its receptor
VEGFR3 is mainly restricted to tip cells at the extremities of
growing blood vessels (Tammela et al., 2008). In the brain,
we have previously shown that VEGF-C stimulates neurogene-
sis via direct cell-autonomous actions of VEGFR3 in neural
cells. Deletion of Vegf-c impairs neural development in both
Xenopus and mouse embryonic brains, and conditional dele-
tion of Vegfr3 within NSCs affects neurogenesis in the adult
mouse SVZ (Calvo et al., 2011; Le Bras et al., 2006). We
hypothesized that VEGF-C-VEGFR3 signaling might affect
hippocampal NSCs in mice and humans, thereby controlling
neurogenesis.
Here, we examined the role of VEGFR3 and its mechanism of
action in adult hippocampal NSCs. We show that the VEGF-C/
VEGFR3 pathway is a positive signal that selectively promotes
NSC activation and conversion into progenitor cells in mice.
Moreover, VEGFR3 signaling is conserved in human NSCs
where VEGF-C activates ERK- and AKT-signaling pathways.
Taken together, these data identify VEGF-C/VEGFR3 as a novel
signaling pathway in mammalian NSCs that may be targeted
therapeutically to improve neurogenesis.
RESULTS
Vegfr3 and Vegf-c Expression in the Hippocampal DG
We characterized the expression of Vegfr3 in the adult hippo-
campus using Vegfr3::YFP BAC-transgenic mice (Calvo et al.,
2011). YFP labeled capillaries and neural cells localized along
the SGZ (Figure 1A). Flow cytometric analysis of dissociated
DG cells confirmed that 16% of neural cells (CD31 non-endo-
thelial cells) were YFP-expressing cells, hereafter referred to as
Vegfr3YFP cells (Figures 1B and S1A). Quantitative RT-PCR
(qRT-PCR) showed that Vegfr3 transcripts are highly enriched
in Vegfr3YFP cells compared to DG neural cells, whereas lower
levels of the two other VEGFR familymembers Vegfr1 and Vegfr2
were found in Vegfr3YFP cells (Figures 1C and S1B). qRT-PCR
also showed enrichment of ligand Vegf-c transcripts in Vegfr3YFP
cells, suggesting possible autocrine VEGF-C/VEGFR3 signaling
in these cells (Figure S1B). In addition, prominent VEGF-C
expression was seen in DG cells surrounding the SGZ by X-galCell Rstaining of VegfcLacZ+ knockin mice and antibody staining
(Figures 1D and 1E), indicative of possible paracrine VEGF-C
signaling to Vegfr3YFP cells.
To examine whether this ligand-receptor system functioned
in hippocampal neurogenesis, we determined which type of
neural cells expressed VEGFR3. About half of Vegfr3YFP cells
(55%) exhibited a RGL morphology characteristic of NSCs
(type-1a) and stained positive for GFAP, Nestin, or BLBP radial
glia markers (Figures 1F–1H and S1C). Almost all Vegfr3YFP
RGL cells expressed GFAP (99%), including a 17% subpopula-
tion that lacked Nestin expression. Previous reports showed
that GFAP+/Nestin RGL cells are quiescent NSCs and sug-
gested that GFAP+/Nestin+ RGL cells are activated NSCs (De-
Carolis et al., 2013), which would indicate that Vegfr3YFP RGL
cells include both quiescent and activated NSCs. The other
45% of Vegfr3YFP cells lacked radial processes (Figure 1G).
Less than 10% of those cells exhibited weaker YFP and stained
for the IPCmarkers Ascl1 and Tbr2, and the rest included S100b+
astrocytes (15%) and non-radial Tbr2 cells that may corre-
spond to non-radial NSCs (20%). DCX+ neuroblasts as well
as postmitotic interneurons were excluded from the Vegfr3YFP
population (Figures 1F, 1H, and S1C). Flow cytometric analysis
of Vegfr3YFP cells confirmed that they include a majority of
S100b+/Glast+/GFAP+ astroglial cells (65%–70%) and Sox2+
(50%) cells (Figure S1D; Table S1). RNA-sequencing analysis
(RNA-seq) also showed enrichment of transcripts encoding
NSPC markers in Vegfr3YFP cells, and specific expression of
GFAP, Nestin, Blbp, Ascl1, Tbr2, and Sox2 in Vegfr3YFP cells
was confirmed by qRT-PCR and flow cytometric analysis (Fig-
ures S1E and S2A; Table S2).
Analysis of proliferation showed that Vegfr3YFP RGL cells are
mainly quiescent (Ki67) whereas non-radial Vegfr3YFP cells
include a few dividing cells (5% Ki67+; Figure 1I). Following a
short BrdU-pulse (3 hr) to label proliferating NSCs and IPCs,
60% of BrdU+ cells were Vegfr3YFP cells (Figures 1J and 1K).
Altogether, these data show that Vegfr3 expression character-
izes NSCs and declines in neural progenitor cells in the adult hip-
pocampal SGZ (Figure 1L).
VEGF-C/VEGFR3 Signaling Activates Hippocampal
NSCs In Vitro
To test the stem cell properties of Vegfr3YFP cells, we sorted
Vegfr3YFP and Vegfr3YFP-negative DG cells and analyzed their
ability to form neurospheres, self-renew, and differentiate into
neural cell types in vitro (Figure 2). We found that neurospheres
formed exclusively from Vegfr3YFP cells, but not from the frac-
tion of Vegfr3YFP-negative cells, which establishes that Vegfr3YFP
cells are NSCs (Figure 2A). Neurospheres derived from Veg-
fr3YFP cells were able to self-renew for at least six passages,
confirming the presence of NSCs with long-term self-renewal
capacity (Figure 2B). Vegfr3YFP neurosphere cells transferred
onto Matrigel differentiated into Tuj1+ neurons (13%) and
GFAP+ astrocytes (71%) but rarely into O4+ oligodendrocytes
(0.9%), which is consistent with previous reports showing that
DG NSCs generate only very few oligodendroglial cells (Bona-
guidi et al., 2011; Figure 2C). Vegfr3YFP cells are therefore
NSCs, which maintain self-renewal and multilineage differentia-
tion capacities.eports 10, 1158–1172, February 24, 2015 ª2015 The Authors 1159
(legend on next page)
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Addition of recombinant VEGF-C (50 ng/ml) had no effect on
cell survival (Figure 2D). However, VEGF-C-stimulated Vegfr3YFP
cells generatedmore neurospheres (Figure 2E). The activation of
Vegfr3YFP cells by VEGF-C was blocked by treatment with a
blocking antibody against VEGFR3 (31C1), indicating that the
response to VEGF-C is VEGFR3 dependent (Figure 2E).
To get a molecular readout of VEGF-C action on hippocampal
NSCs, we performed RNA-seq. As shown in Figure S2B and Ta-
ble S2B, VEGF-C-treated Vegfr3YFP cells, but not Vegfr3YFP-nega-
tive cells, strongly upregulated mRNA expression of regulators of
the G1-S transition, such as cyclin D/E and cyclin-dependent ki-
nases Cdk1/2, and of factors regulating chromosomal DNA repli-
cation. Furthermore, VEGF-C stimulation appears to drive NSCs
from their quiescent state toward a proliferating progenitor state.
In VEGF-C-treated cells, the expression of NSCmarkers such as
Notch1/2 (Ables et al., 2010), Hes5 (Imayoshi et al., 2013),
Ctnnb1(b1-catenin) (Lie et al., 2005), Bmpr1 (bone morphoge-
netic protein receptor) (Mira et al., 2010), Mhi1/2 (Mushashi1/2)
(Okano et al., 2005), Bmi-1 (Fasano et al., 2009), and Rest (Abra-
jano et al., 2010) are downregulated whereas the expression of
progenitor cell markers Ascl1 (Kim et al., 2008; Lugert et al.,
2012), Sox21 (Matsuda et al., 2012), and Numb (Aguirre et al.,
2010; Petersen et al., 2002) are upregulated (Figure S2B; Table
S2B). To confirm the effect of VEGF-C on cell cycle progression,
we analyzed the cell cycle activity of Vegfr3YFP cells. After over-
night culture in the presence or absence of VEGF-C, cells were
stained with Pyronin Y/ Hoechst 33342 and analyzed by flow cy-
tometry (Figure 2F). VEGF-C treatment of Vegfr3YFP cells, but not
of Vegfr3YFP-negative cells, promotes a significant increase of cells
in G1 phase (Figure 2F). Taken together, these data demonstrate
that VEGF-C/VEGFR3 signaling in NSCs initiates cell cycle entry
and conversion of quiescent cells into proliferating progenitor
cells.
Maintenance of Hippocampal Neurogenesis In Vivo
Requires VEGFR3
We next investigated consequences of inducible Vegfr3
deletion in hippocampal NSCs in vivo, using GlastCreERT2 to
delete Vegfr3flox/flox allele (Glast iDR3) (Figures 3 and S3).Figure 1. Vegf-c/Vegfr3 Are Expressed by Adult Hippocampal Stem Ce
(A) Coronal DG section of an adult Vegfr3::YFP mouse. YFP expression is detec
(B) Isolation of Vegfr3YFP cells from the DG of adult Vegfr3::YFPmice. After exclusi
(C) qRT-PCR analysis of FACS-sorted cells from the DGof Vegfr3::YFP adult mice
DG neural cells (non-endothelial DG cells) and Vegfr3YFP-negative cells. n = 3 indep
(D and E) Coronal DG section of adult VegfclacZ/+ mouse stained with X-gal and
higher level of VEGF-C expression in SGZ.
(F) Representative images of coronal DG sections in adult Vegfr3::YFPmice stain
and Tbr2), neuroblasts (DCX), and neurons (NeuN) (red).
(G) Quantification of Vegfr3YFP SGZ cells by their morphology. Percentage of Ve
(H) Quantification of Vegfr3YFP SGZ cell subtypes according to their antigen exp
counted from three to six sections.
(I) 5% of Vegfr3YFP SGZ cells has entered the cell cycle (Ki67+). n = 100–150 cel
(J) Vegfr3YFP cells represent 60% of BrdU+ SGZ cells. Most BrdU+ Vegfr3YFP cells
cells counted from five sections.
(K) Vegfr3YFP SGZ cell morphology and activity. An anti-GFAP Ab labels RGLs (wh
non-radial YFP+ cells.
(L) Comparison of the expression of Vegfr3YFP and other stage-specific markers
The scale bars represent 100 mm (A, D, and E) and 16 mm (F and K).
See also Figure S1.
Cell RThe GlastCreERT2 driver line allows the targeting of Glast+
NSCs that express Vegfr3. Restricted expression of Glast in
glial cells excluded non-radial progenitor cells in the DG (Fig-
ure S3A; DeCarolis et al., 2013; Mori et al., 2006). Mice were
sacrificed 1 or 5 months after Tx treatment to test the effects
of Vegfr3 deletion in neurogenesis. Intercross of GlastCreERT2
mice with ROSA26 and mT/mG reporter lines led to genetic
recombination in >65% of SGZ cells, indicating that Glast-
CreERT2 likely drove mosaic deletion of Vegfr3 in hippocampal
NSCs (Figures S3A and S3B). Genetic recombination of Vegfr3
locus was assessed by PCR in Tx-treated Glast iDR3 mice
(Figure S3C). Glast iDR3 and control (Vegfr3flox/flox) animals
were given a 3 hr BrdU pulse prior to sacrifice to label acti-
vated NSCs (Figure 3A). One-month Tx-Glast iDR3 and control
mice showed similar numbers of BrdU+ SGZ cells and DCX+
neuroblasts (Figures 3B–3E). This result was expected
because Vegfr3 deletion occurs in Glast+ NSCs that rarely
divide and slowly differentiate into DCX+ cells (DeCarolis
et al., 2013). In contrast, 5-month Tx-Glast iDR3 mice showed
a 40% decrease in the number of BrdU+ NSCs and DCX+ neu-
roblasts compared to controls (Figures 3B–3E). The number of
GFAP+Nestin+ RGL cells and of astrocytes in the hilus was
similar between controls and Glast iDR3 mice (Figures 3F
and 3G). The number of RGL cells was also not altered in Glast
iDR3; Vegfr3::YFP mice expressing YFP in RGL cells (Fig-
ure S3D). Altogether, these data indicate that decline of hippo-
campal neurogenesis in Glast iDR3 is not caused by a primary
loss of NSCs or by an abnormal neuron/astrocyte differentia-
tion balance. Anti-active caspase 3 antibody labeling and
TUNEL staining of the DG showed only rare cells engaged in
programmed cell death (PCD) in both Tx-control and -Glast
iDR3 mice, indicating that Vegfr3 deletion did not induce
PCD in DG cells (data not shown). Therefore, Vegfr3 loss of
function in NSCs does not compromise NSC survival and
renewal but selectively impairs NSC activation and conversion
into proliferative IPCs.
Decline of hippocampal neurogenesis is associated with
cognitive impairments and an enhancement of fear and anxiety
in both mice and humans (Encinas and Sierra, 2012; vanlls
ted both in vessels and SGZ cells. White dotted line indicates SGZ.
on of CD31+ endothelial cells, a subset of Vegfr3YFP cells were sorted by FACS.
. Vegfr3 transcripts are specifically enriched in Vegfr3YFP cells compared to total
endent experiments; bars: mean ± SEM; Student’s t test: p < 0.05 (*).
of wild-type mouse labeled with anti-VEGF-C Ab (E). White arrows indicate a
ed with Abs against markers of RGL (GFAP and Nestin), progenitor cells (Ascl1
gfr3YFP RGL cells expressing GFAP and Nestin.
ression. y axis: % of YFP+ marker+ cells/YFP+ cells. Total 30–500 cells were
ls/section, counted from seven sections. Bars: mean ± SEM.
are non-radial cells (98%), and only a few of them are RGL cells (2%). n = 30–50
ite), but not YFP+-non-radial cells. A 3-hr pulse of BrdU (red) labels exclusively
in SGZ cells. Vegfr3YFP expression is specific to NSCs and progenitor cells.
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Figure 2. VEGF-C/VEGFR3 Signaling Activates Hippocampal NSCs In Vitro
(A and B) Neurosphere cultures derived from sorted Vegfr3YFP and Vegfr3YFP-negative cells. The formation of neurospheres was only observed in Vegfr3YFP cell
cultures that can self-renew for at least six successive passages.
(C) Representative images and quantification of neurosphere differentiation. Vegfr3YFP cells differentiate into TuJ1+ neuron (green), GFAP+ astrocyte (blue), and
very few O4+ oligodendrocyte (red).
(D) Cell death was quantified by TUNEL staining.
(E) Representative images and quantification of neurospheres after treatment with VEGF-C (50 ng/ml) and a VEGFR3-function-blocking antibody (31C1).
(F) FACS profile and cell cycle analysis of control Vegfr3YFP cells and VEGF-C-treated Vegfr3YFP cells after Pyronin Y/Hoechst 33342 staining.
The scale bars represent 50 mm (A and C).
Student’s t test: p < 0.05 (*); p < 0.005 (**); not significant (ns). Bars: mean ± SEM; n = 3–5 independent experiments.
See also Figure S2.
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Wijngaarden and Franklin, 2013). We reasoned that decreased
neurogenesis in 5-month Tx-Glast iDR3 mice might lead to
behavioral defects. Five-month Tx-Glast iDR3 and -age-
matched control mice were subjected to two paradigms to
assess anxiety and locomotor activity: the elevated plus maze
(EPM) test (Pellow et al., 1985) and the open-field (OF) test
(Gould et al., 2009), respectively (Figures 3H, 3I, and S3E–
S3K). Five-month Tx-Glast iDR3 mice displayed an anxiety
phenotype in the EPM task, which was not due to a change in
locomotor activity (Figures 3H, 3I, and S3E–S3K). Altogether,
these results suggest a VEGFR3-dependent correlation between
the decline of hippocampal neurogenesis and an increase of
fear/anxiety status that manifests in middle-aged mice.
VEGF-C/VEGFR3 Signaling Activates Hippocampal
NSCs In Vivo
Because VEGF-C treatment drives NSC cell cycle entry in vitro,
we investigated whether VEGF-C/VEGFR3 signaling also pro-
moted NSC activation in vivo. VEGF-C was overexpressed
during 2 to 3 weeks within the hippocampus of C57BL/6 adult
mice by stereotaxic injection of adeno-associated virus (AAV)
encoding full-length VEGF-C (AAV-VEGF-C) above the DG (Fig-
ure 4A). AAV-EGFP was used as a control, and GFP expression
in the hippocampal region showed that all animals had been
efficiently infected (Figure S4A). VEGF-C induced a 2-fold in-
crease in the number of BrdU+ SGZ cells compared to control
(Figure 4B). Consequently, the number of hippocampal DCX+
cells was increased, as shown at 5 weeks after AAV-VEGF-C in-
jection (Figure 4C). No changes in the density of DG capillaries
were observed in AAV-VEGF-C-treated compared to control
animals (Figures S4B and S4C). The effect of VEGF-C on NSC
activation is therefore unlikely to be a secondary consequence
of angiogenesis.
To determine whether VEGF-C acted specifically on Vegfr3YFP
SGZ cells, AAV-VEGF-C was administered to adult Vegfr3::YFP
mice. Two weeks following AAV-VEGF-C infection, BrdU+
Vegfr3YFP cells increased around 60% in number compared to
AAV-EGFP-injected controls (Figures 4D and 4E). Especially,
the number of BrdU+ Vegfr3YFP RGL cells increased in AAV-
VEGF-C-treated mice, suggesting that VEGF-C targets and acti-
vates quiescent Vegfr3YFP NSCs (Figures 4F and 4G).
We expected that loss of Vegfr3 function in NSCs should
abolish the response to VEGF-C. AAV-VEGF-C or AAV-EGFP
was delivered into the hippocampus of Glast iDR3 mice and
controls 3 weeks after Tx injection (Figure 4H). Two weeks later,
Tx-treated control mice responded robustly to AAV-VEGF-C
treatment by a significant increase in the number of BrdU+
NSCs. In contrast, VEGF-C overexpression failed to promote
NSC proliferation inGlast iDR3mice (Figures 4I and 4J). VEGFR3
is therefore required for the response of hippocampal NSCs to
VEGF-C, suggesting that VEGF-C/VEGFR3 signaling activates
NSCs in vivo.
VEGFR3 Signaling Regulates Exercise-Induced
Activation of Hippocampal NSCs
We asked whether VEGF-C/VEGFR3 signaling controlled the
NSC response to running activity, which promotes hippocam-
pal NSC activation. First, we characterized the response ofCell RVegfr3YFP cells (Figure 5A). Running Vegfr3::YFP mice showed
a robust increase in the number of BrdU+ Vegfr3YFP cells
compared to sedentary controls (Figure 5B). The total population
of Vegfr3YFP cells was not increased (Figure S5A), but BrdU+
Vegfr3YFP cells significantly increased (Figures 5B and S5B).
Therefore, running activity promotes activation of Vegfr3YFP
cells. This effect occurs in the absence of significant vascular
remodeling (Figures S5C–S5E). As shown in Figure S5F, running
activity had no significant effect on the level of Vegfc expression
but increased Vegfr3 transcript expression in the DG. Vegfr3
expression likely amplifies in Vegfr3YFP cells because the num-
ber of these cells remained stable. Altogether, these data
indicate that the running-activity-induced hippocampal neuro-
genesis involves the activation of Vegfr3YFP NSCs and the upre-
gulation of Vegfr3 expression in these cells.
To determine whether VEGFR3 was required for the exer-
cise-induced activation of Vegfr3YFP NSCs, Glast iDR3 and
control mice were housed with a running wheel for 3 weeks af-
ter Tx treatment (Figure 5C). Glast iDR3 mice displayed a
normal running activity with similar running distance compared
to control mice (Figure S5G). However, Glast iDR3 mice were
unable to activate running-induced neurogenesis, and the num-
ber of their BrdU+ SGZ cells was comparable with controls
(Figures 5D and 5F). In contrast, running still increased the
number of DCX+ neuroblasts in Glast iDR3 mice similar to con-
trols (Figures 5E and 5G). A possible explanation for the lack of
effect on the DCX+ cells is that the loss of NSCs in Tx-Glast
iDR3 mice might be compensated for by the increased prolifer-
ation of early neuroblasts (Tbr2+DCX+), which is known to
be induced by running activity (Hodge et al., 2008). Therefore,
hippocampal NSC activation in response to running activity is
VEGFR3 dependent but does not affect short-term production
of newborn neurons.
VEGFR3 Activates ERK- and AKT-Signaling Pathways in
Human NSCs
To determine whether VEGFR3 signaling is conserved in hu-
man NSCs and to identify downstream targets of VEGFR3, we
analyzed VEGFR3 expression and signaling pathways in cultures
of NSCs derived from human embryonic stem cells (hESCs)
(H1 andH9cell lines). hESCswere differentiated into free-floating
NSC-containing spherical neural masses (SNMs) (Figures S6A–
S6C). Western blot and immunostaining analyses demonstrate
that SNMs derived from either H9 or H1 hESCs express
VEGFR3, but not VEGFR2 (Figures 6A, 6B, and S6D). VEGFR3+
cells display elongated cytoplasmic processes that correspond
mainly to BLBP-positive NSCs, but not DCX neuroblasts, under
both 3D- and flat-culture conditions (Figures 6C and S6E).
hNSC treatment with VEGF-C stimulates cell division (Fig-
ure 6D). The mitotic response to VEGF-C is preceded by a rapid
induction of VEGFR3 phosphorylation (Figure 6E). VEGF-C also
strongly activates intracellular signals including ERK and AKT
phosphorylation (Figure 6F). At a later time point (15 min),
VEGF-C treatment stimulates AKT-downstream-signaling path-
ways including glycogen synthase kinase 3b (GSK3b) (Figure 6F).
GSK3b is inhibited by pAKT and regulates cell cycle entry, cell
proliferation, and cell fate (Hur and Zhou, 2010). MAZ51, an indo-
linone that blocks VEGFR-3 signaling (Kirkin et al., 2004), inhibitseports 10, 1158–1172, February 24, 2015 ª2015 The Authors 1163
Figure 3. Vegfr3 Deletion in Adult Hippocampal NSPCs
(A) Schedule of Tx and BrdU administration to induce Vegfr3 deletion in NSCs and label-activated NSCs.
(B and C) Representative images of coronal DG sections from control (upper panel) and Glast iDR3 mice (lower panel) at indicated time points. Sections are
stained for BrdU (red), DAPI (blue), and DCX (green). The scale bars represent 70 mm.
(legend continued on next page)
1164 Cell Reports 10, 1158–1172, February 24, 2015 ª2015 The Authors
VEGF-C-induced AKT phosphorylation in hESC-derived NSCs
(Figure S6F). Therefore, VEGF-C/VEGFR3 regulates down-
stream signals controlling NSC activation, providing a molecular
explanation for the NSC behavioral changes observed following
VEGF-C/VEGFR3 signaling manipulation.
DISCUSSION
We here identify a growth-factor-receptor-signaling pathway
that promotes NSC activation during hippocampal neurogene-
sis. We show that Vegfr3 is expressed by mouse hippocampal
NSCs and that VEGF-C/VEGFR3 signaling is necessary for
activation and conversion of NSCs into progenitor cells. Further-
more, we demonstrated that VEGF-C/VEGFR3 signaling is
evolutionarily conserved in human NSCs, where it promotes
cell proliferation and activates ERK/AKT pathways. To our
knowledge, VEGF-C/VEGFR3 is the first known growth-factor-
signaling pathway that selectively promotes NSC activation,
suggesting that VEGF-C could be therapeutically used to
enhance neurogenesis in humans.
We found that, like type-B astrocytes of the SVZ (Calvo et al.,
2011), hippocampal NSCs exhibit Vegfr3YFP reporter expression
and a specific enrichment of Vegfr3 transcripts. Expression of
YFP in all RGL cells and the exclusive generation of neuro-
spheres from Vegfr3YFP DG cells strongly suggest that Vegfr3
is characteristic for hippocampal NSCs. The Vegfr3::YFPmouse
adds to the fewmodels of transgenic reporter lines, such asNes-
tin- (Dranovsky et al., 2011; Encinas et al., 2006) and Hes5-re-
porter mice (Lugert et al., 2010), allowing the detection and
sorting of adult NSCs. The level of YFP reporter expression
was much higher in NSCs than progenitors, indicating that
Vegf3 is downregulated along with the asymmetric cell division
of activated NSCs into progenitor cells.
Three independent lines of evidence demonstrate a direct
requirement of VEGFR3 in NSC activation. First, VEGF-C treat-
ment of Vegfr3YFP cells, but not Vegfr3YFP-negative cells, acti-
vates cell cycle entry; second, genetic deletion of Vegfr3 in
NSCs impairs neurogenesis; and third, VEGF-C-induced NSC
activation is lost in Vegfr3 mutant mice. Vegfr3 deletion in
NSCs decreases the populations of activated NSCs and neuro-
blasts, without affecting the pool of NSCs in middle-aged mice.
VEGFR3 activity is therefore not necessary for NSC mainte-
nance but required for the generation of progenitors and neuro-
blasts, suggesting that VEGF-C/VEGFR3 signaling regulates
activation of cell division in NSCs. This hypothesis is reinforced
by RNA-seq data showing that VEGF-C stimulation shifts NSCs
from their undifferentiated state toward a proliferating progen-
itor state. VEGF-C/VEGFR3 signaling in NSCs downregulates
the expression of Bmi-1 and Rest, which interact with a broad
array of transcriptional and epigenetic regulatory cofactors to
maintain stemness and inhibit NSC differentiation (Abrajano(D and E) Quantification of BrdU+ cells and DCX+ cells in the DG of control and G
(F and G) Representative images and quantification of RGL cells (GFAP+Nestin+
Glast iDR3 mice at 5 months post-Tx administration. The scale bars represent 1
(H and I) Quantification of OF and EPM test.
Student’s t test: p < 0.05 (*); not significant (ns). Bars: mean ± SEM.
See also Figure S3.
Cell Ret al., 2010; Fasano et al., 2009). This suggests that activation
of VEGFR3 by VEGF-C de-represses the NSC differentiation
program. VEGF-C/VEGFR3 signaling in NSCs is also charac-
terized by upregulated expression of factors that are manda-
tory checkpoint regulators of the cell cycle. Although novel in
the context of NSCs, this finding is not surprising when viewed
from an angiogenesis perspective. VEGF-C is a well-known
mitogen for VEGFR3+ lymphatic endothelial cells and mediates
downstream signaling through activation of ERK and AKT
(Koch and Claesson-Welsh, 2012), which suggests that these
downstream signaling events are conserved between endothe-
lial cells and NSCs.
The sources of VEGF-C for inducing NSC activation as well
as themechanisms regulating Vegfr3 expression in NSCs remain
to be determined. NSCs contain Vegf-c transcripts, suggesting
that, besides paracrine VEGF-C from DG cells, autocrine
VEGF-Cmayactivate VEGFR3at the cellmembrane. Thediscon-
tinuousprocessofNSCactivation also implies thatVEGF-Cavail-
abilitymaybe regulated by translational or post-translational pro-
cesses in NSC, perhaps through control of VEGF-C maturation
by enzymes such as CCBE1 (collagen- and calcium-binding
epidermal growth factor domains 1) (Le Guen et al., 2014). NSC
activation is moreover likely to be controlled by a tight regulation
of VEGFR3 expression levels.We found thatVegfr3 expression in
DG cells is physical activity dependent, suggesting that it could
be regulated by activity-dependent epigenetic mechanisms,
such as DNA methylation that modulates neurogenesis (Guo
et al., 2014; Jobe et al., 2012; Saharan et al., 2013) and also con-
trols Vegfr3 expression in endothelial cells (Quentmeier et al.,
2012). Notch signaling is another regulator that inhibits VEGFR3
expression in endothelial cells (Benedito et al., 2012), suggesting
that Notch may maintain NSCs quiescence by regulating Vegfr3
expression. Conversely, we show that VEGFR3 activation in
NSCs downregulates Notch and its downstream targets, sug-
gesting that functional antagonism between VEGFR3 and Notch
could switch NSC fate from quiescence to activation. Interest-
ingly,Notch1 deletion in NSCs (Ables et al., 2010) induces similar
phenotype to Vegfr3 deletion in NSCs, i.e., a delayed reduction in
the populations of dividing NSPCs and neuroblasts.
Another novelty of our study is the finding that VEGFR3
expression is conserved in human NSCs, where it promotes
proliferation and regulates ERK and AKT, GSK3b signaling
cascades in response to VEGF-C. Through VEGFR3, VEGF-C
activates several downstream signaling cascades promoting
transcription, such as ERK for mitogen-stimulated proliferation
(Phoenix and Temple, 2010), and translation, such as mTOR
and S6K signals, which regulate cell survival and cell fate deci-
sions (Bordey, 2014; Hur and Zhou, 2010). VEGF-C is therefore
able to rapidly and simultaneously regulate cell cycle entry
and differentiation processes in NSCs, which likely explains its
potent role in mouse hippocampal neurogenesis.last iDR3 mice at 1 month and 5 months post-Tx administration.
cells in SGZ, white arrow) and astrocytes (GFAP+ cells in hilus) of control and
6 mm.
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Figure 4. VEGFR3 Mediates VEGF-C-Induced Proliferation in Hippocampal NSCs
(A) Intra-hippocampal injection of AAV9-GFP (control) and -VEGF-C. At 2 to 3 weeks after AAV infection, mice were given a 3-hr pulse of BrdU and analyzed to
quantify proliferation and neuroblast production in the DG.
(B and C) Quantification of BrdU+ cells and DCX+ cells in the SGZ of control and VEGF-C-treated mice.
(D and E) Representative images and quantification of BrdU+Vegr3YFP cells after VEGF-C overexpression in Vegfr3::YFP mice. VEGF-C treatment increases
BrdU+Vegr3YFP cells in SGZ (white arrows). The scale bars represent 35 mm.
(F and G) Representative images and quantification of BrdU+Vegr3YFP RGL cells after VEGF-C overexpression in Vegfr3::YFPmice. VEGF-C treatment increases
BrdU+Vegr3YFP RGL cells in SGZ (white arrows). The scale bars represent 35 mm.
(legend continued on next page)
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We found that, in addition to impaired neurogenesis, Tx-Glast
iDR3 showed increased anxiety behavior, suggesting that
VEGFR3 signaling in DG NSCs may contribute to emotional
response. Although further research is required to reinforce this
finding, it confirms previous genetic evidence that manipulation
of neurogenesis alters behavior in models of anxiety and depres-
sion (Eisch and Petrik, 2012; Gross et al., 2002; Saxe et al., 2006;
Snyder et al., 2011). However, VEGFR3 is expressed by other
Glast-expressing cells besides hippocampal NSCs, including ta-
nycytes in the hypothalamic median eminence and a few astro-
cytes in the amygdala (Hou et al., 2011; Robins et al., 2013).
These regions are involved in the regulation of the hypothalam-
ic-pituitary-adrenal (HPA) axis that controls reactions to stress
as well as mood and emotions (Canteras et al., 2010), suggesting
that VEGFR3 signaling in NSC/astrocytesmay act on behavior by
modulating the functioning of the limbic-HPA axis.
VEGF-C can promote angiogenesis (Gaa´l et al., 2013) but only
weakly when compared to VEGF-A, because VEGFR3-signaling
activity is mainly restricted to sprouting tip cells and inhibited in
other endothelial cells by Notch signaling (Tammela et al., 2011).
VEGF-C may thus be a candidate factor to enhance NSC activa-
tion, without unwanted effects on other cell types. Altogether,
our findings are consistent with the possibility that VEGF-C acti-
vation of NSCs could improve age-related decline in hippocam-
pal neurogenesis and associated mood defects, such as those
seen in Alzheimer’s disease.
EXPERIMENTAL PROCEDURES
Animals
C57/Bl6 mice (Jackson Laboratories) were maintained in the Animal
Research Center at Yale University. The Vegfr3::YFP (Calvo et al., 2011),
GlastCreERT2, Vegfr3flox/flox (Haiko et al., 2008), and Vegf-cLacZ/+ (Karkkainen
et al., 2004) mice have been described previously. GlastCreERT2 mice were
crossed with Vegfr3flox/flox mice to generate NSC-specific and Tx-inducible
Vegfr3 mutant mice (Glast iDR3). Animals were sacrificed the days indicated
in each experiment. All experiments were approved by the IACUC of Yale
University.
TX Treatment
To induce genetic recombination, 2-month-old adult mice were injected intra-
peritoneally (i.p.) with tamoxifen (TX) once per day for 10 consecutive days (as
indicated in the experiments) at a dose of 2 mg per day.
BrdU Administration
BrdU (Sigma) was administered to the adult animals via a single i.p. injection
(300 mg/kg) 3 hr before sacrifice. The brains were processed for immunohis-
tochemistry as described below.
Tissue Collection and Immunohistochemistry
Animals were anesthetized with isoflurane inhalation and perfused first with
PBS and then with 4% paraformaldehyde (PFA). Brains were post-fixed over-
night in 4% PFA and then washed with PBS. Brain coronal vibratome sec-
tions (40 mm) of brains were incubated with serum-free blocking solution
(DAKO) for 1 hr at 4C and then incubated overnight at 4C with the primary(H) Schedule of Tx treatment, AAV9 infection, and BrdU administration in control
(I and J) Representative images and quantification of BrdU+ SGZ cells in control (up
overexpression increases BrdU+ SGZ cells (red) in control mice, but not in Glast
Student’s t test: p < 0.05 (*); ns, not significant. Bars: mean ± SEM.
See also Figure S4.
Cell RAb (listed in Table S1) diluted in PBS containing 0.1% Triton X-100 (PBST).
After washing, sections were incubated with the corresponding conjugated
secondary. For immunolabeling of SNMs, cryosections (20 mm) were then
performed and stained as indicated above. DAPI was used for nucleus
counterstaining.
b-Galactosidase Staining
Sections were immersed in 10 mM Tris-HCl (pH 7.3) containing 0.005% Na-
deoxycholate, 0.01% Nonidet P40, 5 mM ferrocyanide, 5 mM ferricyanide,
2 mM MgCl2, and 1 mg/ml X-gal at 37
C until the signal became visible.
Q-PCR
Vegfr3::YFPmice (total 108mice) were used for FACS and further Q-PCR anal-
ysis of Vegfr3YFP cells. RNA was isolated from sorted cells using the Nucleo-
Spin RNA XS (Macherey-Nagel) and from tissues using RNeasy lipid tissue
kit (QIAGEN). Real-time quantitative PCR reactions were performed in dupli-
cate using the CFX-96 Real Time PCR system (Bio-Rad). Primers (Quantitect
primer assays) were purchased from QIAGEN.
FACS
The DG was carefully isolated from the hippocampus; treated with papain
(0.8 mg/ml; Worthington) for 30 min at 37C; and then mechanically dissoci-
ated in PBS containing 5% FCS, 0.3% glucose, and 5 mM HEPES in order
to obtain a single-cell suspension. Dissociated cells were stained with anti-
CD31 Ab to exclude endothelial cells. Aria was used for sorting with the
DIVA software (BD Biosciences).
Cell Cultures
FACS-sorted cells were plated at 1 3 104 cells/well in 24-well plates. Neu-
rospheres were grown in Complete Culture Medium (CCM) (DMEM/F12-
Glutamax [GIBCO], 20 mg/ml insulin [Sigma], 1/200 B-27 supplement
[GIBCO], 1/100 N-2 supplement [GIBCO], 0.3% glucose, 5 mM HEPES,
and 100 U/ml of penicillin/streptomycin) enriched with 20 ng/ml bFGF
and 20 ng/ml EGF (both from Peprotech) during 10 days in vitro (DIV). To
analyze cell differentiation, mechanically dissociated 10-DIV-derived neuro-
spheres were plated onto Matrigel-coated glass coverslips in CCM without
EGF/bFGF for 7 DIV. To test the effect of VEGF-C on neurosphere forma-
tion and cell survival, cells were plated in CCM containing EGF and bFGF
alone or with recombinant rat VEGF-C (50 ng/ml; Reliatech) and rat
31C1- IgG2a antibodies (5 mg/ml; Imclone). Neurosphere formation was
scored at 5 DIV by counting the number of neurospheres in culture. For sur-
vival assay, cells were incubated overnight on glass coverslips with or
without VEGF-C (50 ng/ml), fixed, and labeled with the TUNEL detection
kit (Roche 11 684 809 910).
Intra-cerebral Stereotaxic Injections
Animals were anesthetized with isoflurane, and skull holes were drilled over-
lying the hippocampus on both hemispheres. The site of infusion was at
the following coordinates relative to bregma: anteroposterior, 1.8 mm;
mediolateral,1.8 mm; and dorsoventral,1.8 mm. Twomicroliters of control
AAV-EGFP (control) or AAV-VEGF-C were infused at a flow rate of 0.5 ml/min.
Two to three weeks after injection, the brains were processed for immunohis-
tochemistry as described.
Stereological Analysis
The marker (BrdU, DCX, and YFP)-positive cells were counted in a one-in-
six series of five sections (40 mm, 240 mm apart) throughout the rostro-
caudal extent of the dorsal DG. The sections stained with DAPI were used
to measure DG area using Volocity software (PerkinElmer). The total number
of marker+ cells was determined by summing the number of marker+ cellsand Glast iDR3 mice.
per panel) and -Glast iDR3mice (lower panel) after VEGF-C treatment. VEGF-C
iDR3 mice. The scale bar represents 35 mm.
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Figure 5. VEGFR3 Is Required for Exercise-Induced NSPC Proliferation
(A) Schedule of voluntary running activity and BrdU administration for Vegfr3::YFP mice.
(B) Quantification of BrdU+ cells and BrdU+Vegfr3YFP cells in the SGZ of sedentary control and running Vegfr3::YFP mice.
(C) Schedule of Tx treatment, voluntary running activity, and BrdU administration in control and Glast iDR3 mice.
(D–G) Representative images and quantification of BrdU+ SGZ cells and DCX+ cells in control (upper panel) and Glast iDR3 mice (lower panel), either sedentary
(left) or running (right). BrdU+ cells (red), DAPI (blue), and DCX+ cells (green) are shown. Running induces proliferation of NSCs in control mice, but not inGlast iDR3
mice. A similar number of neuroblasts is generated in control and Glast iDR3 mice. The scale bar represents 35 mm.
Student’s t test: p < 0.05 (*); p < 0.001 (***); not significant (ns). Bars: mean ± SEM.
See also Figure S5.and multiplying this number of cells by the number of serial sections (number
of cells/series 3 6). Total volume was determined by summing the traced
DG areas for each section multiplied by the distance between sections
sampled (area 3 240 mm). To calculate the number of marker+ cells per vol-
ume (1 mm3), the total number of marker+ cells was divided by the total
volume.1168 Cell Reports 10, 1158–1172, February 24, 2015 ª2015 The AuthhESC-Derived NSC Cultures
We have progressively differentiated hESCs into free-floating SNMs that
contain self-renewing, multipotent NSCs according to a protocol (Cho et al.,
2008). All experiments have been performed on SNMs derived from two
different H1 (male) and H9 (female) hESC lines (Allegrucci and Young, 2007).
Detailed information is provided in Supplemental Experimental Procedures.ors
Figure 6. VEGFR3-Signaling Pathway in Human NSCs
(A) Western blot analysis of VEGFR2 and VEGFR3 expression in H1 human-ESC-derived NSCs. VEGFR3migrates as three molecular weight species: 195, 175,
and 125 kDa (arrows). EB, embryoid bodies; ESC, embryonic stem cells; HUVEC, human umbilical vein endothelial cells; NP, neural progenitors; SNM, spherical
neural mass.
(B) SNMs stained with anti-hVEGFR2 and -hVEGFR3 antibodies as indicated. The scale bars represent 100 mm.
(C) SNMs stained for VEGFR3 (green), BLBP (red; astroglia/NSC), or DCX (red; neuron) and DAPI (gray). The scale bars represent 20 mm.
(D) Representative image of phospho-histone H3 staining. The scale bar represents 100 mm.
(E) Phospo-VEGFR3 analysis by immunoprecipitation.
(F) Western blot analysis of the phosphorylation state of ERK, AKT (tyrosine 398 and serine 473), and GSK3b in SNMs after VEGF-C stimulation.
Student’s t test: p < 0.05 (*). Bars/lines: mean ± SEM.
See also Figure S6.Statistics
A two-tailed, unpaired Student’s t test or Mann-Whitney test were done to
determine statistical significance (Graph-Pad Prism 6). Differences were
considered statistically significant if the p value was 0.05 (*p < 0.05; **p <
0.01; ***p < 0.005). Error estimates were displayed as SEM.Cell RACCESSION NUMBERS
According to the MIAME guidelines, all transcriptomic data were submitted to
a MIAME compliant repository, NCBI’s Gene Expression Omnibus (GEO), and
are accessible through the GEO accession number GSE55621.eports 10, 1158–1172, February 24, 2015 ª2015 The Authors 1169
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at http://
dx.doi.org/10.1016/j.celrep.2015.01.049.
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